Dmitry V. Shcheblyakov

4.0k total citations
36 papers, 353 citations indexed

About

Dmitry V. Shcheblyakov is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Dmitry V. Shcheblyakov has authored 36 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 11 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Dmitry V. Shcheblyakov's work include SARS-CoV-2 and COVID-19 Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Influenza Virus Research Studies (7 papers). Dmitry V. Shcheblyakov is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Influenza Virus Research Studies (7 papers). Dmitry V. Shcheblyakov collaborates with scholars based in Russia, United States and United Kingdom. Dmitry V. Shcheblyakov's co-authors include Denis Y. Logunov, Gintsburg Al, Amir I. Tukhvatulin, Boris S. Naroditsky, I. B. Esmagambetov, М. М. Шмаров, Alina S. Dzharullaeva, Inna V. Dolzhikova, Andrei V. Gudkov and Ilya Gitlin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Dmitry V. Shcheblyakov

29 papers receiving 345 citations

Peers

Dmitry V. Shcheblyakov
Christoph Kreer Germany
Tamarand L. Darling United States
Sietske K. Rosendahl Huber Netherlands
Siddhartha Kumar Bhaumik India
Deleah Pettie United States
Maddy L. Newby United Kingdom
И. Л. Тутыхина Russia
Vanessa M. Cowton United Kingdom
Yuval Avnir United States
Alexander S. Hahn Germany
Christoph Kreer Germany
Dmitry V. Shcheblyakov
Citations per year, relative to Dmitry V. Shcheblyakov Dmitry V. Shcheblyakov (= 1×) peers Christoph Kreer

Countries citing papers authored by Dmitry V. Shcheblyakov

Since Specialization
Citations

This map shows the geographic impact of Dmitry V. Shcheblyakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry V. Shcheblyakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry V. Shcheblyakov more than expected).

Fields of papers citing papers by Dmitry V. Shcheblyakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry V. Shcheblyakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry V. Shcheblyakov. The network helps show where Dmitry V. Shcheblyakov may publish in the future.

Co-authorship network of co-authors of Dmitry V. Shcheblyakov

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry V. Shcheblyakov. A scholar is included among the top collaborators of Dmitry V. Shcheblyakov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry V. Shcheblyakov. Dmitry V. Shcheblyakov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zubkova, Olga V., Denis I. Zrelkin, Daria V. Voronina, et al.. (2025). Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever. Medical Immunology (Russia). 27(1). 153–168.
2.
Esmagambetov, I. B., et al.. (2025). A modified single-domain antibody candidate for the treatment of botulism caused by botulinum toxin type A. SHILAP Revista de lepidopterología. 25(1). 58–70.
3.
4.
5.
Sluchanko, Nikolai N., Dmitry V. Shcheblyakov, I. A. FAVORSKAYA, et al.. (2024). Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain. Biochemistry (Moscow). 89(7). 1260–1272.
6.
Zubkova, Olga V., Olga Popova, Anna V. Kovyrshina, et al.. (2024). Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors. SHILAP Revista de lepidopterología. 24(3). 294–311.
7.
Zubkova, Olga V., Olga Popova, Daria V. Voronina, et al.. (2024). <i>In vitro</i> and <i>in vivo</i> tropism and biodistribution of recombinant simian adenovirus type 25. SHILAP Revista de lepidopterología. 101(5). 594–605. 1 indexed citations
8.
Fomina, Daria, Anna V. Kovyrshina, Inna V. Dolzhikova, et al.. (2023). Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period. Frontiers in Immunology. 14. 1259725–1259725. 2 indexed citations
9.
FAVORSKAYA, I. A., et al.. (2023). Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies. SHILAP Revista de lepidopterología. 23(1). 76–89. 1 indexed citations
10.
Popova, Olga, et al.. (2023). Development and characterization of a vector system based on the simian adenovirus type 25. Bulletin of Russian State Medical University. 3 indexed citations
11.
Shcheblyakov, Dmitry V., Alina S. Dzharullaeva, I. B. Esmagambetov, et al.. (2023). Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A. Frontiers in Immunology. 14. 1098302–1098302. 19 indexed citations
12.
Esmagambetov, I. B., Dmitry V. Shcheblyakov, Inna V. Dolzhikova, et al.. (2023). rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19. Frontiers in Immunology. 14. 1129245–1129245. 6 indexed citations
13.
Voronina, Daria V., Dmitry V. Shcheblyakov, I. A. FAVORSKAYA, et al.. (2022). Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection. Viruses. 14(11). 2485–2485. 9 indexed citations
14.
Voronina, Daria V., et al.. (2021). Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses. PubMed. 13(4). 33–41. 11 indexed citations
15.
Al, Gintsburg, Denis Y. Logunov, Inna V. Dolzhikova, et al.. (2021). Impact of pathogen reduction methods on immunological properties of the COVID‐19 convalescent plasma. Vox Sanguinis. 116(6). 665–672. 14 indexed citations
16.
Esmagambetov, I. B., et al.. (2021). Comparison of different technologies for producing recombinant adeno-associated virus on a laboratory scale. SHILAP Revista de lepidopterología. 21(4). 266–278. 7 indexed citations
17.
Popova, Olga, Olga V. Zubkova, Denis I. Zrelkin, et al.. (2021). Review of candidate vaccines for the prevention of Lassa fever. SHILAP Revista de lepidopterología. 66(2). 91–102.
18.
Esmagambetov, I. B., Dmitry V. Shcheblyakov, Olga L. Voronina, et al.. (2021). Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection. PubMed. 13(4). 53–63. 16 indexed citations
19.
Dzharullaeva, Alina S., Amir I. Tukhvatulin, Alina S. Erokhova, et al.. (2018). Stimulation of Dectin-1 and Dectin-2 during Parenteral Immunization, but Not Mincle, Induces Secretory IgA in Intestinal Mucosa. Journal of Immunology Research. 2018. 1–13. 12 indexed citations
20.
Shcheblyakov, Dmitry V., et al.. (2018). THE USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF EBOLA VIRUS DISEASE. Problems of Virology. 63(6). 245–249. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph Kreer Breakdown of academic impact, for papers by Tamarand L. Darling Breakdown of academic impact, for papers by Sietske K. Rosendahl Huber Breakdown of academic impact, for papers by Siddhartha Kumar Bhaumik Breakdown of academic impact, for papers by Deleah Pettie Breakdown of academic impact, for papers by Maddy L. Newby Breakdown of academic impact, for papers by И. Л. Тутыхина Breakdown of academic impact, for papers by Vanessa M. Cowton Breakdown of academic impact, for papers by Yuval Avnir Breakdown of academic impact, for papers by Alexander S. Hahn
Rankless by CCL
2026